Large-cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-12-18
Clinical Trial Update: Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma [Phase 2]
This clinical trial update reports results from a Phase 2 study of SGN-30 in patients with primary cutaneous anaplastic large cell lymphoma.